Buy, Sell or Hold Credo Technology After the Selloff to $150?
Briefly

Buy, Sell or Hold Credo Technology After the Selloff to $150?
Credo designs high-speed interconnect components used inside AI data centers, including active electrical cables, retimers, optical DSPs, and SerDes chiplets that move data between GPUs, switches, and racks at up to 1.6 terabits per second. Shares fell sharply after a large prior run, raising the importance of whether hyperscaler capital expenditures still support the business. Fiscal Q3 results showed strong growth, with revenue up 201.5% year over year, non-GAAP EPS above consensus, and operating income rising 471.2%. Management also identified new addressable markets. The balance sheet shows $1.3 billion in cash with minimal debt, while risks include valuation demanding flawless execution, gross margin compression guidance, higher inventory, and insider selling.
"Credo designs high-speed plumbing inside AI data centers. Active electrical cables, retimers, optical DSPs, and SerDes chiplets move bits between GPUs, switches, and racks at speeds up to 1.6 terabits per second. That narrow product set sits directly in the path of every dollar Amazon ( NASDAQ:AMZN), Microsoft ( NASDAQ:MSFT), and others spend on AI infrastructure. The selloff reflects a stock that ran 282% in a year. At that level, even good news struggles to clear the bar."
"Fiscal Q3 revenue was $407.01 million, up 201.5% year over year, beating consensus by 5%. Non-GAAP EPS came in at $1.07 against a $0.94 consensus. Operating income jumped 471.2% on the same revenue base. That is genuine operating leverage at scale. Management opened three new addressable markets on the call. ZeroFlap optics, Active Line Cards, and OmniConnect memory solutions, each described as a multi-billion-dollar opportunity."
"The balance sheet carries $1.3 billion in cash + equivalents with essentially no debt, and institutions have been buying, with Swedbank lifting its stake 47.1% to roughly $296.8 million. Of the analysts covering the stock, 4 rate it Strong Buy, 12 Buy, and 1 Hold, with a consensus target of $209.09. The argument for and against this stock is unusually balanced."
"The valuation here demands flawless execution, and if management fails to do that, I'd expect more selloffs. The forward multiple of 32x only narrows the gap if growth holds. Q4 guidance pointed to gross margin compression from 68.6% to 64.0%-66.0%, and inventory increased to $207.9 million. Insiders sold roughly $50.4 million in shares over recent months. But despite all that, the bear case is still weak and rests mostly on the valuation side."
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]